E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/25/2007 in the Prospect News PIPE Daily.

New Issue: Avalon Pharmaceuticals to raise $20 million from sale of shares

By Laura Lutz

Des Moines, May 25 - Avalon Pharmaceuticals, Inc. plans to conduct a private placement of shares for up to $20 million.

The company intends to sell up to 3,838,772 shares at $5.21 each. Investors will also receive warrants for at total of 959,693 shares. Each warrant will be exercisable at $6.00 for five years.

As of Friday morning, settlement was expected later in the day.

Avalon is a biopharmaceutical company based in Germantown, Md.

Issuer:Avalon Pharmaceuticals, Inc.
Issue:Shares
Amount:$20 million
Shares:3,838,772
Price:$5.21
Warrants:For 959,693 shares
Warrant expiration:Five years
Warrant strike price:$6.00
Pricing date:May 25
Settlement date:May 25
Stock symbol:Nasdaq: AVRX
Stock price:$5.33 at close May 25

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.